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Using Enhanced Sampling Molecular Dynamics Techniques to Probe the
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The molecular mechanism of spontaneous polypeptide folding and insertion
into a membrane, as well as its exit and unfolding, is of interest from several
perspectives, including the action of antimicrobial peptides, the folding and
degradation of membrane proteins, and medical applications of pH-triggered
insertion peptides. A notable example is pH (Low) Insertion Peptide (pHLIP),
which is a water-soluble polypeptide derived from helix C of bacteriorhodopsin
that has the ability to insert into a membrane at acidic pH to form a stable trans-
membrane a-helix. The insertion process takes place in three stages: pHLIP is
unstructured and soluble in water at neutral pH(state I), unstructured and bound
to the surface of a membrane at neutral pH(state II), and inserted into the mem-
brane as an a-helix at low pH(state III). Our hypothesis is that, there is a
connection between the free energy change of binding /insertion and pKa of
insertion. To test this hypothesis, we used enhanced sampling molecular
dynamics (MD) techniques (steered MD and umbrella sampling) to investigate
the molecular interactions of a C-terminal-truncated pHLIP variant, pHLIP-1,
with a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer. The
goal is to characterize the free energy of binding from state I to state II and the
free energy of insertion from state II to state III (a-helical peptide insertion) and
to identify key structural aspects that govern these processes. Our results agree
well with the previous experiments, providing the first steps in establishing a
direct relationship between the thermodynamics and pKa of pHLIP peptide
insertion.
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Localized delivery is vital for the successful development of novel and effec-
tive therapeutics for the treatment of cancer. Currently, most targeting methods
rely upon expression of protein biomarkers to promote tumor targeting and
killing. Despite their promises, such strategies suffer from two major draw-
backs: Biomarkers are not specific to cancer cells, which can result in off-
target toxicity, and cancer cells have a tendency to evolve quickly, which
can lead to a loss of biomarkers and therapy resistance. However, nearly all
solid tumors have a low extracellular pH, regardless of their tissue or cellular
origin. Moreover, tumors’ aggressiveness and metastatic potential are fostered
at low extracellular pH. For these reasons, acidosis is a hallmark of tumor pro-
gression and may provide an opportunity for tumor-targeted therapy. The tar-
geting and delivery described herein is based on the pH(Low) Insertion
Peptide (pHLIP), a unique delivery peptide that can selectively target tumors
in mice based solely on their acidity rather than a specific marker. Our group
focuses on developing new strategies to inhibit cancer cell growth by delivering
therapeutics to cells using pHLIP. We hypothesize that the localized targeting
achievable with pHLIP when combined with potent therapeutics will synergize
to create an efficacious treatment for cancer. In the present study, we investi-
gate the efficacy of pHLIP to deliver the highly potent and clinically validated
microtubule inhibitor monomethyl auristatin E (MMAE) to cancer cells in vitro
in a pH dependent manner. We show that pHLIP and one of its variants chosen
to optimize targeting, can induce a potent cytotoxic effect in cancer cells,
including triple negative breast cancer cells, against which none of the current
targeting strategies are effective. Furthermore, we demonstrate that these
pHLIP-MMAE drug conjugates effectively target breast tumors in mice.
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In naked viruses, membrane breaching is a key step that must be performed for
genome transfer into the target cells. Despite its importance, the mechanisms
behind this process remain poorly understood. The small protein VP4, codified
in the genome of most Picornavirales order viruses, has been shown to be
involved in membrane alterations. Here we have analyzed the permeabilization
activity of the natively non-myristolated VP4 protein from Triatoma virus(TrV), a virus belonging to the Dicistroviridae family within the Picornavirales
order. The VP4 protein was produced as a Maltose Binding Protein (MBP)
fusion to achieve its successful expression. This recombinant VP4 protein is
able to produce membrane permeabilization in model membranes in a lipid-
dependent manner. The membrane-induced permeability was also influenced
by the pH, being greater at higher pH values. We demonstrate that the perme-
abilization activity elicited by the protein occurs through discrete pores that are
reversibly inserted on the membrane. Sizing experiments using fluorescent dex-
trans, cryo-electron microscopy imaging and other additional techniques
showed that recombinant VP4 forms heterogeneous proteo-lipidic pores rather
than common proteinaceous channels. These results show that VP4 protein is
involved in the membrane alterations required for genome transfer or cell entry
steps during dicistrovirus infection.
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The precise mechanism of cell entry by influenza remains poorly understood,
despite many years of research. Entry into the cytoplasm is preceded by a mem-
brane fusion event between the virion and endosomal membrane, mediated by
the fusion protein hemagglutinin. Hemagglutinin resides in the viral membrane
with one transmembrane helix. Its ectodomain is trimeric, and this enforces
close proximity between the three helices in the viral membrane. Previous
research has demonstrated that the transmembrane domain of hemagglutinin
is crucial to its pathogenicity, and that while some mutations are allowed,
full viral fusion to the target membrane is blocked by drastic deletions or
replacement with a GPI anchor. We have conducted molecular dynamics sim-
ulations of the hemagglutinin transmembrane domain to understand any inter-
actions that may occur between the domains and postulate how they can impact
hemagglutinin function. Preliminary results indicate that the helices can asso-
ciate in a membrane, without the ectodomain present. We have used a multi-
scale simulation approach to examine the stability of encounter complexes in
order to identify key interactions and predict changes that would disrupt
them. First, coarse-grained simulations were used to generate encounter com-
plexes between helices, which were then simulated at atomic resolution to
test the stability of each complex and identify specific interactions in the mem-
brane. Our goal is to discover stabilizing interactions that can shed light into
functional data on possible hemagglutinin transmembrane domain mutants.
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Lassa fever is a hemorrhagic fever endemic in West Africa. Currently the only
available treatment, ribavirin, is only effective in the early stages of infection.
Due to the limited efficacy of ribavirin, new drugs are needed to combat Lassa
fever. In recent years many peptides have been developed as entry inhibitors
against numerous viruses. Many of these peptides share a common trait; they
are somewhat hydrophobic and have a tendency to partition into membranes.
It is hypothesized that many of these peptides disrupt the physical chemistry
of the membrane, inhibiting the virus from fusing with the host cell. In this
study hydrophobic membrane interacting peptides were selected and chal-
lenged against a Lassa pseudovirus. This pseudovirus is composed of an HIV
core (pSG3Denv) and the Lassa envelop (Josiah strain), and allows us to study
the virus, a BSL-4 pathogen, in a BSL-2 environment. Infection of the pseudo-
virus was detected using TZM HeLa cells, a cell line containing a gene that en-
codes luciferase which is promoted by tat, an HIV core protein. Initially ten
hydrophobic peptides were selected; nine of which were discovered for charac-
teristics other than antiviral activity. Interestingly, some were found to inhibit
the virus while others increased viral activity. Of the peptides that inhibited the
virus, the two peptides that showed the greatest antiviral activity were discov-
ered from the same peptide library. More peptides from that library were then
tested against the Lassa pseudovirus, most of which showed antiviral activity
and low toxicity. In the next phase of this work these peptides will provide
an archetype for the design of a combinatorial peptide library to optimize Lassa
viral entry inhibition.
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There is a constant need for new malaria drugs because of the perpetual
development of resistance to current therapies. To facilitate the costly drug
